Froedtert Hospital & Medical College of Wisconsin | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer	invasive breast carcinoma	Active, not recruiting	Phase 2	2026-07-27		NCT04243616
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Active, not recruiting	Not applicable	2026-07-20		NCT03704662
Long-term Follow-up Study of Patients Receiving CAR-T Cells	B-cell chronic lymphocytic leukemia, B-cell neoplasm, B-cell non-Hodgkin lymphoma, Blood Protein Disorders, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, cardiovascular disorder, diffuse large B-cell lymphoma, follicular lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary central nervous system lymphoma, vascular disorder, vascular hemostatic disease, viral infectious disease	Recruiting	Not stated	2025-11-10		NCT03375619